Development of Monoclonal Antibody-Based EIA for Tetranor-PGDM which Reflects PGD(2) Production in the Body

Tetranor-PGDM is a metabolite of PGD(2). Urinary tetranor-PGDM levels were reported to be increased in some diseases, including food allergy, Duchenne muscular dystrophy, and aspirin-intolerant asthma. In this study, we developed a monoclonal antibody (MAb) and a competitive enzyme immunoassay (EIA)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunol Res
Main Authors: Nagata, Nanae, Masuko, Sakura, Inoue, Rikako, Nakamura, Tatsuro, Aritake, Kosuke, Murata, Takahisa
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8096570/
https://ncbi.nlm.nih.gov/pubmed/33997056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5591115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados